Compared to non-use, intake of ASA was associated with increased risk of other causes of death.
Detailed information on diet, tobacco and alcohol use, intake of selected drugs, family history of cancer, and other risk factors were obtained with a baseline questionnaire.
This cross-sectional survey used a standardised questionnaire developed by the WHO to collect core data on common risk factors such as tobacco use, intake of fruits and vegetables, physical inactivity, blood pressure levels, and body mass index.
On the other hand, it included more variables such as alcohol use, intake of vegetables and family history of MI and stroke and the numerical values of HRs were higher.
In subanalyses, we adjusted for other potential confounders (body mass index, hypertension, history of depression, antidepressant use, intake of alcohol, fish and fruit, and participation in phase two cardiac rehabilitation), but this did not change the estimates (≤4%).
After further adjusting for body mass index, race, smoking status, calcium supplement use, intake of vitamin D, dietary intake of vitamin A and protein, alcohol intake, and diuretic use, the adjusted relative risk for women in the group with the highest intake of dietary calcium compared with women with the lowest intake was 0.56 (95% confidence interval 0.37 to 0.86, P=0.009 for trend).
The scenario tested here used an intake of IPO much greater than likely to be consumed in practice.
Using daily intake of metals (DIM) and reference oral dose (R fD), the HRI value was obtained using the following equation.
Intake responses were standardized among species by using proportional intake of the hydrolysates (referred to as "preference scores") that were calculated by dividing the intake of the hydrolysate diet by the total test diet intake for that session (HC+Cel or GE+Cel).
Amino acid digestibility was calculated as a coefficient using the intake of the individual amino acid minus the output in droppings, divided by input.
